Developing Resiliency and Exercise Using AI-based Messaging

Starting soon · Not applicable

Conditions studied: Diabetes Mellitus Type 2

In brief

This is a randomized, controlled pilot trial to examine the feasibility, acceptability, and preliminary efficacy of the DREAM program, an 8-week message-based intervention to promote physical activity and well-being in adults with type 2 diabetes.

Key facts

Study ID

NCT07225283

Run by

Massachusetts General Hospital

People needed

20

Starts

2026-09-01

Expected to finish

2027-03-31

Last updated by the study team

2026-05-18

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 2 diabetes diagnosis (A1c ≥6.5%, fasting glucose ≥126 mg/dL)
• Suboptimal physical activity (score < 5 on the Medical Outcomes Study Specific Adherence Scale physical activity item)
• Access to a smartphone (i.e., Android or iOS) or computer with access to the internet and an internet browser

You may not qualify if…

• An unrelated condition limiting physical activity
• Participation in any other programs focused on physical activity or well-being
• A cognitive disturbance precluding participation or informed consent
• Current pregnancy or plan to become pregnant in the next 16 weeks
• Inability to speak/write fluently in English
• Use of non-basal insulin

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.